The Cardiovascular Innovation Awards are searching for novel ideas and innovations in devices, diagnostics and services, which improve the delivery of care in cardiovascular health including chronic diseases such as diabetes and respiratory conditions.
Emeritus Professor of Analytical Pharmacology at King's College
Sir James received the Nobel Prize for Physiology and Medicine in 1988 for the development of beta-blockers, and the anti-ulcer histamine receptor blocking drugs, including the best-selling Tagamet.
Professor Sir Bruce Keogh is responsible for the Clinical Quality and Strategy and the Medicines, Pharmacy and Industry Directorates within the Department of Health. He is also Director General of Informatics.
